In an effort to ignite regenerative medicine and transform the way we think about health and aging, Aubrey de Grey spends his time on airplanes between England and Silicon Valley, as well as to conferences and events where he can evangelize his message to those who help accelerate his mission.
How should we go about developing medicine in the near future? he asks a large group who showed up in Louisville for Idea Festival, who committed their time to be there because they’re interested in innovation, advanced learning and making the world a better place.
He encouraged people to think about aging and dying differently. Death from aging is not only “natural causes, it’s anything that mainly kills older people.”
A few stats: about 150,000 people die per day worldwide, two thirds of them die of aging which equates to 100,000 per day. In the USA, the proportion is over 90%.
None of us are getting any younger and those of us who live in the United States know how broken our healthcare system is…we don’t like to think what that means while we’re still under 50 because frankly it’s too painful to go there. It’s only when we see our aging parents go through the system, where things don’t work, their live savings are wiped out within months, service is inefficient and disagnoses happen more than they should but because traditional doctors aren’t thinking holistically rather than incompetence.
Aging is considered ghastly but also inevitable. It is rational to put ghastly but inevitable things out of our minds, even if we have to be amazingly irrational in order to do so. He calls this rational denial.
“But what if that inevitability became unclear?” he asks. The focus of his talk revolved around the following issues and how we can make a difference:
- Repair versus retardation.
- Specifics: the seven types of damage
- Intracellular junk/medical bioremediation
- Longevity: escape velocity: the concept
- Some evidence that LEV is realistic
De Grey made it clear that his focus is centered around health not longevity which is where regenerative medicine comes in, which he defines as any intervention that seeks to restore a tissue/organ to its state before it suffered damage.
Aging is essentially when metabolism ongoingly causes damage and damage eventually causes pathology over time. Options for intervention divide into two different approaches: the gerontology and the geriatrics approach.
The geriatrics approach is better than nothing he says but the gerontology approach isn’t much better.
Damage can be slowed down to some degree and other things along the way can be repaired. He asserts that there are seven deadly things that make up damage in our bodies:
- Junk – inside cells
- Junk – outside cells
- Cells – too few
- Cells – too many
- Mutations – chromosomes
- Mutations – mitochondria
- Protein Crosslinks
If we can develop bioremediation in a way that is sustainable, we can tackle aging diseases that cause damage and eventually lead to our death. Robust human rejuvenation he says, can give the middle-aged 30 years of extra healthy life.
Repairing damage periodically can buy us time. In other words, you can slow aging down.
First generation therapies should be likely to transform the health quality of a 60 year old into a 90 year old body. If you start early, you benefit from buying time and putting off some of the damage from aging by 20-30 years.
Then, 20-30 years later, you can do another therapy that has decades of research and improvement.
Essentially therapies double efficacy only every 42 years. The result is that you can add decades to your life, particularly if you start the therapies early enough.
In Aubrey’s words: “we have a humanitarian duty to fix aging.” Hear hear Aubrey. Hear hear!
Maverick Aubrey de Grey is the editor-in-chief of the journal Rejuvenation Science and co-author of the 2007 book Ending Aging. He challenges the most basic assumption underlying the human condition —that aging is inevitable. He argues instead that aging is a disease –one that can be cured if it’s approached as “an engineering problem.” His plan calls for identifying all the components that cause human tissue to age, and designing remedies for each of them —forestalling disease and eventually pushing back death…providing for an indefinite lifespan. He calls this approach Strategies for Engineered Negligible Senescence (SENS).
Renee Blodgett is the founder of We Blog the World. The site combines the magic of an online culture and travel magazine with a global blog network and has contributors from every continent in the world. Having lived in 10 countries and explored nearly 80, she is an avid traveler, and a lover, observer and participant in cultural diversity.
She is also the CEO and founder of Magic Sauce Media, a new media services consultancy focused on viral marketing, social media, branding, events and PR. For over 20 years, she has helped companies from 12 countries get traction in the market. Known for her global and organic approach to product and corporate launches, Renee practices what she pitches and as an active user of social media, she helps clients navigate digital waters from around the world. Renee has been blogging for over 16 years and regularly writes on her personal blog Down the Avenue, Huffington Post, BlogHer, We Blog the World and other sites. She was ranked #12 Social Media Influencer by Forbes Magazine and is listed as a new media influencer and game changer on various sites and books on the new media revolution. In 2013, she was listed as the 6th most influential woman in social media by Forbes Magazine on a Top 20 List.
Her passion for art, storytelling and photography led to the launch of Magic Sauce Photography, which is a visual extension of her writing, the result of which has led to producing six photo books: Galapagos Islands, London, South Africa, Rome, Urbanization and Ecuador.
Renee is also the co-founder of Traveling Geeks, an initiative that brings entrepreneurs, thought leaders, bloggers, creators, curators and influencers to other countries to share and learn from peers, governments, corporations, and the general public in order to educate, share, evaluate, and promote innovative technologies.
